Sinovac Biotech Ltd. (SVA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 644.46M |
| Enterprise Value | -326.69M |
| P/E Ratio | -6.45 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 1.04 |
| Price/Book Ratio | 0.07 |
| Enterprise/Revenue | -1.13 |
| Enterprise/EBITDA | 83.96 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | June 30, 2024 |
| Profit Margin | -0.22 |
| Operating Margin | -1.22 |
| Return On Assets | -0.01 |
| Return On Equity | -0.01 |
| Revenue | 448.27M |
| Revenue/Share | 4.5 |
| Gross Profit | 266.75M |
| EBITDA | -6.03M |
| Net Income | -99.92M |
| Diluted EPS | -1.06 |
| Total Cash | 10.57B |
| Total Cash/Share | 112.67 |
| Total Debt | 324.51M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 10.31 |
| Book Value Per Share | 120.7 |
| 52-Week Change | 0 |
| 52-Week High | 6.47 |
| 52-Week Low | 6.47 |
| Moving Average 50 Days | 6.47 |
| Moving Average 200 Days | 6.47 |
| Average Volume | 0 |
| Shares Outstanding | 71.86M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 55 |
| Trailing Annual Dividend Yield | 850.08 |
| Payout Ratio | -3.28 |
| Last Split Factor | N/A |
| Last Split Date | N/A |